🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
The goal of this clinical trial is to learn if drug Mirogabalin works to tr...
Status
Recruiting
Location
Bangladesh Medical University
Start Date
2025-10-01
Trial ID
NCT07451431
Treatments Being Tested
This study will examine the impact of providing patient-reported outcomes m...
Status
Completed
Location
The University of Michigan
Start Date
2021-09-14
Trial ID
NCT05026853
Treatments Being Tested
PLANNING PHASE- Qualitative interviews with Healthcare Professionals to ass...
Status
Completed
Location
AAKHS conference, Dallas
Start Date
2022-11-03
Trial ID
NCT05597046
Treatments Being Tested
The overarching objective of this study is to evaluate the symptom assessme...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-01
Trial ID
NCT03046329
Treatments Being Tested
Objective: To evaluate the (cost-)effectiveness of a new patient-empowered ...
Status
Unknown
Location
Isala
Start Date
2022-07-17
Trial ID
NCT05379127
Treatments Being Tested
With an increasing number of rectal cancer (RC) survivors, we see a rising ...
Status
Completed
Location
Aalborg University Hospital, Department of Surgery
Start Date
2016-02-26
Trial ID
NCT03622437
Treatments Being Tested
This study aims to evaluate the impact of AbbVie Care 2.0 on adalimumab's c...
Status
Completed
Location
Instituto Portugues De Reumatologia /ID# 205963
Start Date
2017-11-15
Trial ID
NCT03223012
This is a cluster randomized trial that involves training regions of physic...
Status
Completed
Location
BenchMark
Start Date
2017-05-24
Trial ID
NCT03168165
Treatments Being Tested
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested